Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


Innovative NZ medical invention destined for US

Click for big version

(Left to right) : Adrian Whiteman (New Zealand Trade and Enterprise Sector Manager for Specialised Manufacturing), Dr Michael East (surgeon and inventor) and Paul Morrison (manufacturer) with the Manipuseal, a high-tech medical device invented and developed in New Zealand and now destined for the US market.

Innovative New Zealand medical invention destined for America

31 October 2005: A New Zealand invention that had its origins in a surgical rubber gloves is set to launch in to the lucrative American market.

The Manipuseal, a high tech, innovative medical device, designed and developed by Christchurch surgeon, Dr Michael East, and specialist manufacturing company, Insitu Systems Ltd, was recently given approval for its use in the United States by the Federal Drug Administration.

Adrian Whiteman, a Sector Manager for Specialised Manufacturing with New Zealand Trade and Enterprise says getting the FDA approval is a huge step for the small company. "This opens up significant export opportunities as the US currently forms the largest single market for health products."

The Manipuseal is a disposable product designed to be used in Laparoscopic Assisted Vaginal Hysterectomies (LAVH). Employing the Manipuseal makes the key-hole surgery simpler and quicker for surgeons.

Insitu Systems Ltd Product Manager, Ross Bayer, says LAVH procedures are becoming increasingly popular over traditional abdominal or vaginal hysterectomies as they are less traumatic on the patient.

"One of the reasons LAVH procedures are still not widely used," says Bayer, "is they require a greater degree of surgical skill than the alternatives."

"The Manipuseal is designed to make the process easier for surgeons and thereby reduces the risks for the patient, as well as the time it takes to perform the surgery. The procedures allow better visibility and also results in a shorter stay in hospital for the patient."

Insitu Systems Ltd believe the resulting cost savings and patient benefits will be an important selling point in the American market which is struggling against escalating health costs and the growing pressure to perform more and more LAVH procedures.

"Currently about 10 per cent of all hysterectomies performed globally are LAVH procedures and this figure is tracking upwards by at least one per cent a year," says Bayer. "In the US this is about 60,000 patients."

Although the device has been proven and is in use in New Zealand, the costs of entering the American market have proved prohibitive for Insitu Systems Ltd.

"We approached NZTE," says Bayer, "and they stepped in with Growth Services Funding that made it possible for us to go ahead with the FDA application."

Whiteman says that for NZTE getting the device into the US market is an opportunity to showcase an innovative product in a highly specialised market. "The Manipuseal is a brilliant example of New Zealand's capacity for design excellence especially in niche areas such as the health market."

Insitu Systems Ltd chose to work with US-based medical device consultants, MDCI, on the application for the FDA approval.

"They understood the process totally so could help us get the product to a stage where it would pass the requirements. It was vital for us to have that expertise," says Bayer.

"Fortunately, Dr East had eight years of rigorous clinical research data so that in the end the FDA required only a few minor adjustments before giving us approval."

NZTE will continue to help Insitu Systems Ltd by providing Market Development Funding to assist in developing sales of the device in the US.

The company will manufacture and distribute the Manipuseal device from its Christchurch base at Enztec Manufacturing.


© Scoop Media

Business Headlines | Sci-Tech Headlines


CTU 2021 Work Life Survey: COVID And Bullying Hit Workplaces Hard, Huge Support For Increased Sick Leave

New data from the CTU’s annual work life survey shows a snapshot of working people’s experiences and outlook heading out of 2020 and into the new year. Concerningly 42% of respondents cite workplace bullying as an issue in their workplace - a number ... More>>

Smelter: Tiwai Deal Gives Time For Managed Transition

Today’s deal between Meridian and Rio Tinto for the Tiwai smelter to remain open another four years provides time for a managed transition for Southland. “The deal provides welcome certainty to the Southland community by protecting jobs and incomes as the region plans for the future. The Government is committed to working on a managed transition with the local community,” Grant Robertson said. More>>


Economy: Strong Job Ad Performance In Quarter Four

SEEK Quarterly Employment Report data shows a positive q/q performance with a 19% national growth in jobs advertised during Q4 2020, which includes October, November and December. Comparing quarter 4, 2020, with the same quarter in 2019 shows that job ad volumes are 7% lower...More>>

NIWA: 2020 - NZ’s 7th-warmest Year On Record

The nationwide average temperature for 2020, calculated using stations in NIWA’s seven-station temperature series which began in 1909, was 13.24°C (0.63°C above the 1981–2010 annual average). New Zealand’s hottest year on record remains 2016, when... More>>

Quotable Value New Zealand: Property Market Set To Cool From Sizzling To Warm In 2021

Nostradamus himself could not have predicted the strange series of events that befell our world in 2020 – nor the wild trajectory of New Zealand’s property market, which has gone from “doom and gloom” to “boom and Zoom” in record time. Even ... More>>

PriceSpy: Research Reveals How Shopping Behaviours Have Changed This Christmas

According to a new survey* from PriceSpy , almost 50 per cent of Kiwis are looking to shop locally this Christmas in light of Covid-19; The research also found consumers are changing their shopping habits, with one in seven (14 per cent) getting super-organised ... More>>